Skip to main content

Table 1 Published reports on PKR and Alzheimer’s disease

From: PKR involvement in Alzheimer’s disease

Report

Sample

Results

Chang et al. 2002 [45]

Brain

pPKR neuronal accumulation

Peel et al. 2003 [39]

Brain

pPKR neuronal accumulation

Onuki et al. 2004 [32]

Brain

pPKR neuronal accumulation

Paccalin et al. 2006 [71]

PBL

pPKR increased level

Page et al. 2006 [40]

Brain

pPKR increased concentration

Bullido et al. 2008 [74]

DNA

PKR gene association

Damjanac et al. 2009 [72]

PBL

PKR-dependent increases in P53, Redd1

Couturier et al. 2010 [35]

PBL

PKR control of inflammation

Bose et al. 2011 [47]

Brain

Co-localization of pPKR and ptau

Paquet et al. 2012 [69]

Brain

Increased levels of PKR activator PACT

Mouton-Liger et al. 2012 [76]

CSF

Increased levels of PKR and pPKR

Badia et al. 2013 [73]

PBL

Increased levels of PKR RNA in ApoE4 patients

Dumurgier et al. 2013 [77]

CSF

CSF pPKR predicts cognitive decline

Paquet et al. 2015 [79]

Brain

Aβ vaccine reduces pPKR load

Taga et al. 2017 [70]

Brain

Correlations cognitive scores and pPKR load

  1. Non-exhaustive list of published studies that assessed the levels of PKR signals in human AD samples, including brain, peripheral blood lymphocytes (PBL), and cerebrospinal fluid (CSF)